CompoAtlas

Magnesium Bisglycinate

Magnesium Bisglycinate: 1 product on CompoAtlas, with their composition and the regulatory status of each ingredient.

Brand coverage

Products recorded here: each cosmetic GTIN counts once, each supplement declaration separately. Catalogue observations without a GTIN remain identified by page and variant. These counts do not measure the brand’s entire marketed range.

Calculated on 2026-11-08.

FamilyRecorded productsWith a composition or declared componentsWith a dated composition
Cosmetics and cosmetic catalogue observations000
Declared food supplements000

No products in this scope: share cannot be calculated.

Age of known lists. The date is the ingredient photo date when known, otherwise the composition version or official observation date. An administrative decision date is not a composition date. Declared components do not guarantee a complete label list.

Under 2 years
0
2 to 5 years
0
Over 5 years
0
Unknown date
0

Lists observed on the brand site: 0. Retained contributory compositions: 0. A product may have both origins.

Recorded composition differences: 0 barcodes. They may reflect observations from different dates and do not prove an error by the brand.

Composition to complete: 0 products or observations.

To make your pages readable, check robots.txt, public access, GTINs and text lists with the diagnostic tool.

Coverage as JSON, without a key

Recalls in Canada

This brand name appears in the title or product of these records. This mention does not establish that all its products are affected.

The feed provides neither barcodes nor ingredient lists. A recall often targets specific batches: compare your product with the official notice. The dataset also includes safety alerts, not only recalls.

Type I: risk of serious adverse health consequences or death; Type II: possible temporary health effects or a low probability of serious consequences; Type III: adverse health consequences unlikely. Health Canada definitions. Class unspecified when the field is empty.

Canada Recalls and Safety Alerts: cosmetics and natural health products, retrieved 24 October 2026.

Contains information licensed under the Open Government Licence – Canada

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

  1. · Last updated

    Jamieson Laboratories products recall; Tamper-evident seals defective

    Joint pain relief capsule; Magnesium bisglycinate Capsules; Maca capsules

    Packaging

    Type III: adverse health consequences unlikely

    Official notice 81822

  2. · Last updated

    MapleLife Magnesium Bisglycinate 200mg: Undeclared ingredient (Magnesium Oxide)

    MapleLife Magnesium Bisglycinate 200mg

    Product safety

    Type III: adverse health consequences unlikely

    Official notice 81280

  3. · Last updated

    Life Brand Magnesium Bisglycinate 200mg: Undeclared ingredient (Magnesium Oxide)

    Life Brand Magnesium Bisglycinate 200mg

    Product safety

    Type III: adverse health consequences unlikely

    Official notice 78492

  4. · Last updated

    Magnesium Bisglycinate Powder 250- Rose Hip Dragonfruit (2021-05-06)

    Product safety

    Type II: possible temporary health effects or a low probability of serious consequences

    Official notice 62411

  5. · Last updated

    Magnesium Bisglycinate Powder 250 - Berry Hibiscus (2021-05-06)

    Product safety

    Type II: possible temporary health effects or a low probability of serious consequences

    Official notice 62409

Cosmetics in Canada · Natural health products in Canada

Enter to analyse, Shift+Enter for a new line